Lonza to expand inhalation services by adding capabilities at its Tampa (US) site as part of its continued focus on providing bioavailability enhancement series for global customers
With the introduction of this device, Alkem is entering the core inhalation therapeutics and envisaging that the drug will reach the lungs effectively in each inhalation with added patient awareness and adherence programmes
Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Technology Development Board supports commercialisation of Metal Injection Molding of implants
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
New inhalers would have near-zero Global Warming Potential propellant
ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status
Market data indicates that more than twenty percent of the new chemical entities being developed use roller compaction technology in their development and commercialization
Subscribe To Our Newsletter & Stay Updated
